Linc AB
STO:LINC

Watchlist Manager
Linc AB Logo
Linc AB
STO:LINC
Watchlist
Price: 66.1 SEK -0.15% Market Closed
Market Cap: kr3.8B

Net Margin

96.5%
Current
Improving
by 2.5%
vs 3-y average of 94.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
96.5%
=
Net Income
kr-399.6m
/
Revenue
kr-414m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
96.5%
=
Net Income
kr-399.6m
/
Revenue
kr-414m

Peer Comparison

Country Company Market Cap Net
Margin
SE
Linc AB
STO:LINC
3.8B SEK
Loading...
US
BlackRock Inc
NYSE:BLK
165.5B USD
Loading...
US
Blackstone Inc
NYSE:BX
139.4B USD
Loading...
CA
Brookfield Corp
NYSE:BN
109B USD
Loading...
ZA
Ninety One Ltd
JSE:NY1
93.5B ZAR
Loading...
CA
BROOKFIELD ASSET MANAGEMENT LTD
TSX:BAM
107.1B CAD
Loading...
US
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
69.6B EUR
Loading...
US
KKR & Co Inc
NYSE:KKR
81.7B USD
Loading...
CA
Brookfield Asset Management Inc
NYSE:BAM
78.3B USD
Loading...
US
Bank of New York Mellon Corp
NYSE:BK
79.6B USD
Loading...
UK
3i Group PLC
LSE:III
33.3B GBP
Loading...

Market Distribution

Higher than 99% of companies in Sweden
Percentile
99th
Based on 2 084 companies
99th percentile
96.5%
Low
-5 565 412.8% — -5.3%
Typical Range
-5.3% — 7.5%
High
7.5% — 12 228%
Distribution Statistics
Sweden
Min -5 565 412.8%
30th Percentile -5.3%
Median 3%
70th Percentile 7.5%
Max 12 228%

Linc AB
Glance View

Market Cap
3.8B SEK
Industry
Financial Services

Linc AB is an investment company that focuses on long-term share ownership in the Nordic life science market. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2021-05-28. Linc invests in product-oriented companies within the Nordic Life Science industry - primarily in pharmaceutical and medical technology companies. The investments are made in both private and public companies and in research and operational companies. Typically, investments in drug development take place in an earlier phase compared to investments in medical technology. Linc Invest is an active and long-term owner with a wide industrial network to support the portfolio companies. The firm works together with the management, founders and board to realize the inherent potential that exists in the investment, have ambitious plans for further development and expansion and actively participate in the nomination committee work.

LINC Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
96.5%
=
Net Income
kr-399.6m
/
Revenue
kr-414m
What is Linc AB's current Net Margin?

The current Net Margin for Linc AB is 96.5%, which is above its 3-year median of 94.1%.

How has Net Margin changed over time?

Over the last 3 years, Linc AB’s Net Margin has increased from 81.1% to 96.5%. During this period, it reached a low of 52.2% on Mar 31, 2023 and a high of 113.5% on Mar 31, 2025.

Back to Top